Price T Rowe Associates Inc. MD Sells 170,140 Shares of KKR & Co. Inc. (NYSE:KKR)

Price T Rowe Associates Inc. MD lowered its stake in KKR & Co. Inc. (NYSE:KKR) by 10.7% during the 1st quarter, HoldingsChannel reports. The firm owned 1,421,337 shares of the asset manager’s stock after selling 170,140 shares during the period. Price T Rowe Associates Inc. MD’s holdings in KKR & Co. Inc. were worth $142,959,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Blue Trust Inc. increased its position in KKR & Co. Inc. by 197.2% during the fourth quarter. Blue Trust Inc. now owns 318 shares of the asset manager’s stock valued at $26,000 after acquiring an additional 211 shares during the last quarter. Riverview Trust Co bought a new stake in KKR & Co. Inc. during the first quarter valued at about $27,000. Turtle Creek Wealth Advisors LLC purchased a new stake in KKR & Co. Inc. in the fourth quarter worth about $30,000. Missouri Trust & Investment Co raised its stake in shares of KKR & Co. Inc. by 408.9% in the fourth quarter. Missouri Trust & Investment Co now owns 458 shares of the asset manager’s stock worth $38,000 after buying an additional 368 shares during the period. Finally, First United Bank & Trust bought a new position in shares of KKR & Co. Inc. in the fourth quarter worth about $41,000. 76.26% of the stock is owned by institutional investors.

Insider Buying and Selling at KKR & Co. Inc.

In related news, major shareholder Kkr Group Partnership L.P. sold 17,500,000 shares of the company’s stock in a transaction on Monday, May 13th. The stock was sold at an average price of $83.36, for a total value of $1,458,800,000.00. Following the transaction, the insider now directly owns 366,567 shares of the company’s stock, valued at approximately $30,557,025.12. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. In related news, major shareholder Kkr Group Partnership L.P. sold 17,500,000 shares of KKR & Co. Inc. stock in a transaction that occurred on Monday, May 13th. The stock was sold at an average price of $83.36, for a total transaction of $1,458,800,000.00. Following the completion of the transaction, the insider now directly owns 366,567 shares in the company, valued at $30,557,025.12. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, major shareholder Kkr Alternative Assets Llc bought 1,956,182 shares of the firm’s stock in a transaction that occurred on Tuesday, June 4th. The stock was purchased at an average price of $25.56 per share, with a total value of $50,000,011.92. Following the completion of the purchase, the insider now owns 9,688,618 shares in the company, valued at $247,641,076.08. The disclosure for this purchase can be found here. 39.34% of the stock is currently owned by company insiders.

KKR & Co. Inc. Stock Down 0.5 %

KKR & Co. Inc. stock traded down $0.59 during mid-day trading on Monday, reaching $117.92. 914,005 shares of the company were exchanged, compared to its average volume of 4,908,737. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.08 and a current ratio of 0.08. The firm has a market cap of $104.64 billion, a P/E ratio of 26.57, a PEG ratio of 1.06 and a beta of 1.62. KKR & Co. Inc. has a 12-month low of $53.72 and a 12-month high of $120.14. The business has a fifty day moving average of $108.33 and a 200 day moving average of $99.87.

KKR & Co. Inc. (NYSE:KKR) last released its quarterly earnings results on Wednesday, May 1st. The asset manager reported $0.78 EPS for the quarter, missing the consensus estimate of $0.80 by ($0.02). KKR & Co. Inc. had a net margin of 19.38% and a return on equity of 4.52%. The firm had revenue of $986.51 million for the quarter, compared to analysts’ expectations of $989.14 million. Research analysts anticipate that KKR & Co. Inc. will post 3.96 earnings per share for the current fiscal year.

KKR & Co. Inc. Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, May 28th. Shareholders of record on Monday, May 13th were paid a dividend of $0.175 per share. This is a positive change from KKR & Co. Inc.’s previous quarterly dividend of $0.17. The ex-dividend date was Friday, May 10th. This represents a $0.70 dividend on an annualized basis and a yield of 0.59%. KKR & Co. Inc.’s dividend payout ratio is presently 15.70%.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on the stock. Jefferies Financial Group decreased their target price on shares of KKR & Co. Inc. from $115.00 to $113.00 and set a “buy” rating on the stock in a research note on Thursday, May 9th. Evercore ISI increased their price target on KKR & Co. Inc. from $112.00 to $117.00 and gave the stock an “outperform” rating in a research note on Monday, July 15th. TD Cowen dropped their price objective on KKR & Co. Inc. from $157.00 to $145.00 and set a “buy” rating for the company in a research note on Monday, July 8th. StockNews.com cut shares of KKR & Co. Inc. from a “hold” rating to a “sell” rating in a research note on Wednesday, May 15th. Finally, JMP Securities lifted their target price on KKR & Co. Inc. from $108.00 to $112.00 and gave the stock a “market outperform” rating in a report on Tuesday, April 9th. One investment analyst has rated the stock with a sell rating, one has given a hold rating and thirteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, KKR & Co. Inc. currently has an average rating of “Moderate Buy” and a consensus target price of $101.20.

KKR & Co. Inc. Profile

KKR & Co Inc is a private equity and real estate investment firm specializing in direct and fund of fund investments. It specializes in acquisitions, leveraged buyouts, management buyouts, credit special situations, growth equity, mature, mezzanine, distressed, turnaround, lower middle market and middle market investments.